FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40859411000001104: Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2374821000001115 Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2374841000001113 Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Is a Noradrenaline (base) 2mg/2ml solution for infusion ampoules true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Norepinephrine true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has specific active ingredient Norepinephrine bitartrate true Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) 10 ampoule Has AMP True Noradrenaline (base) 2mg/2ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start